Sherri_Ingrey on Nostr: And.... women still defend it It's like their SSRIS total fraud but they LUBS them ...
And.... women still defend it
It's like their SSRIS total fraud but they LUBS them
Recent studies involving nearly 150,000 patients have signaled an end to the ‘magic pill’ era for Ozempic, revealing that long-term users face a 30% higher risk of osteoporosis. Research presented at the 2026 AAOS meeting indicates that the drug may contribute to osteomalacia, or bone softening, at a rate 1.5 times faster than normal.
This skeletal fragility is partly attributed to the rapid loss of muscle mass, which deprives bones of the mechanical stress needed to maintain density.
The "Ozempic Bone" phenomenon is also linked to severe appetite suppression, which can lead to critical nutrient deficiencies in calcium and Vitamin D. To combat these risks, medical experts now urge patients on GLP-1 therapy to prioritize heavy strength training and high protein intake. Regular DXA bone density scansare also becoming a standard recommendation to monitor for early signs of bone thinning while on the medication.”
Published at
2026-04-01 00:28:40 UTCEvent JSON
{
"id": "c16769d56fd0994e65da9bc0b1f3f540f19b2f9bd8892acd0ca65a0484342285",
"pubkey": "4d20ffc67f2d6d5abde4c341c4ec0b40282291f3e269c49d58105b3037e409a5",
"created_at": 1775003320,
"kind": 1,
"tags": [
[
"imeta",
"url https://media.spinster.xyz/56895371386f5a7dc14e61b457bd55401203f0d1aee2bc21d4fc571a09e2ca74.png",
"m image/png",
"dim 519x640",
"blurhash d8BD1n?G4:n,?a?Go#I=_N^*aKIo9bx[?HM{o~ad-oWB"
],
[
"proxy",
"https://spinster.xyz/objects/2852cabf-a560-4bad-ab9f-6bdb820b2608",
"activitypub"
],
[
"client",
"Mostr",
"31990:6be38f8c63df7dbf84db7ec4a6e6fbbd8d19dca3b980efad18585c46f04b26f9:mostr",
"wss://relay.ditto.pub"
]
],
"content": "And.... women still defend it \nIt's like their SSRIS total fraud but they LUBS them\nRecent studies involving nearly 150,000 patients have signaled an end to the ‘magic pill’ era for Ozempic, revealing that long-term users face a 30% higher risk of osteoporosis. Research presented at the 2026 AAOS meeting indicates that the drug may contribute to osteomalacia, or bone softening, at a rate 1.5 times faster than normal.\nThis skeletal fragility is partly attributed to the rapid loss of muscle mass, which deprives bones of the mechanical stress needed to maintain density.\nThe \"Ozempic Bone\" phenomenon is also linked to severe appetite suppression, which can lead to critical nutrient deficiencies in calcium and Vitamin D. To combat these risks, medical experts now urge patients on GLP-1 therapy to prioritize heavy strength training and high protein intake. Regular DXA bone density scansare also becoming a standard recommendation to monitor for early signs of bone thinning while on the medication.”\n\nhttps://media.spinster.xyz/56895371386f5a7dc14e61b457bd55401203f0d1aee2bc21d4fc571a09e2ca74.png",
"sig": "9352bd379231bde3a7fdeb10cd0ce7417588781885cedb0dcad797960a85caba1bdb3704e8f268aaf79d10c0dae084eb573e86d1af7bd2e9170758d5d3b7691b"
}